The Enterprise Value as of December 2025 (TTM) for Aspire Biopharma Holdings, Inc. (ASBP) is 11.23M

According to Aspire Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.23M. This represents a change of -67.67% compared to the average of 34.75M of the last 4 quarters.

Aspire Biopharma Holdings, Inc. (ASBP) Historical Enterprise Value (quarterly & annually)

How has ASBP Enterprise Value performed in the past?

The mean historical Enterprise Value of Aspire Biopharma Holdings, Inc. over the last ten years is 384.67M. The current 11.23M Enterprise Value has changed 192.01% with respect to the historical average. Over the past ten years (40 quarters), ASBP's Enterprise Value was at its highest in in the March 2024 quarter at 530.74M. The Enterprise Value was at its lowest in in the March 2025 quarter at 9.94M.

Aspire Biopharma Holdings, Inc. (ASBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aspire Biopharma Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aspire Biopharma Holdings, Inc. (ASBP) Average Enterprise Value

How has ASBP Enterprise Value performed in the past?

The current Enterprise Value of Aspire Biopharma Holdings, Inc. (ASBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aspire Biopharma Holdings, Inc. (ASBP) Enterprise Value vs. Peers

How is ASBP’s Enterprise Value compared to its peers?

Aspire Biopharma Holdings, Inc.’s Enterprise Value is less than Palisade Bio, Inc. (263.19M), greater than Curis, Inc. (10.37M), less than Leap Therapeutics, Inc. (53.86M), greater than Entero Therapeutics, Inc. (9.37M), greater than Citius Pharmaceuticals, Inc. (8.76M), greater than Daré Bioscience, Inc. (-3098933.00), greater than BriaCell Therapeutics Corp. (10.71M), greater than Processa Pharmaceuticals, Inc. (8.45M), greater than Aditxt, Inc. (5.43M), greater than Hoth Therapeutics, Inc. (6.79M),

Build a custom stock screener for Aspire Biopharma Holdings, Inc. (ASBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspire Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aspire Biopharma Holdings, Inc. (ASBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aspire Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.